Table 2 SARS-CoV-2 seropositivity, malaria prevalence and recognition of malaria antigens in Kwamasimba and Mkokola
Age groups | N | Kwamasimba | Mkokola | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
n | SARS-CoV-2 seropositivity | Malaria antigen recognition | Malaria (BS) | Malaria (mRDT) | n | SARS-CoV-2 seropositivity | Malaria antigen recognition | Malaria (BS) | Malaria (mRDT) | ||
 < 1 | 28 | 13 | 38.5% (5) | 46.2% (6) | 0.0%(0) | 0.0% (0) | 15 | 33.3% (5) | 40.0% (6) | 0.0% (0) | 6.7% (1) |
 1–4 | 91 | 41 | 17.1% (7) | 65.9% (27) | 0.0% (0) | 7.3% (3) | 50 | 22.0% (11) | 34.0% (17) | 4.0% (2) | 2.0% (1) |
 5–9 | 151 | 75 | 25.3% (19) | 78.7% (59) | 6.7% (5) | 13.3% (10) | 76 | 25.0% (19) | 81.6% (62) | 1.3% (1) | 6.6% (5) |
 10–14 | 164 | 103 | 49.5% (51) | 89.3% (92) | 10.7% (11) | 21.4% (22) | 61 | 41.0% (25) | 85.3% (52) | 1.6% (1) | 8.2% (5) |
 15–19 | 67 | 35 | 68.6% (24) | 94.3% (33) | 14.3% (5) | 17.1% (6) | 32 | 50.0% (16) | 87.5% (28) | 3.1% (1) | 9.4% (3) |
 Total | 501 | 267 | 39.7% (106) | 81.3% (217) | 7.9% (21) | 15.4% (41) | 234 | 32.5% (76) | 70.5% (165) | 2.1% (5) | 6.4% (15) |
p-value | Â | Â | 0.001 | 0.001 | 0.006 | 0.017 | Â | 0.007 | 0.001 | 0.988 | 0.221 |
z-score | Â | Â | 4.75 | 4.90 | 2.74 | 2.38 | Â | 2.67 | 6.07 | 0.02 | 1.22 |